Profile data is unavailable for this security.
About the company
XOMA Royalty Corporation is a biotechnology royalty aggregator. The Company’s royalty aggregator business is primarily focused on early to mid-stage clinical assets, primarily in Phase I and II, with significant commercial sales potential that are licensed to funded partners. The Company has a portfolio of economic rights and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The Company's commercial assets include OJEMDA (tovorafenib), IXINITY, XACIATO, VABYSMO (faricimab svoa), DSUVIA (sufentanil sublingual tablet), and MIPLYFFA (arimoclomol). Its Phase III assets include Rilvegostomig (AZD2936), Ficlatuzumab (AV-299), Ovaprene, D-Fi (FCX-007), Seralutinib, Cetrelimab (JNJ-63723283), Ersodetug (RZ358), and Mezagitamab (TAK-079). Its Phase II assets include Acimtamig (AFM13), AFM24, Vosaroxin, Aldoxorubicin, G03-52-01, PBF-680, PBF-677, Vidutolimod (CMP-001), and RZ-402. Its others assets include COM902 and MT-0169.
- Revenue in USD (TTM)47.11m
- Net income in USD9.87m
- Incorporated2025
- Employees13.00
- LocationXoma Royalty Corp2200 Powell Street, Suite 310EMERYVILLE 94608United StatesUSA
- Phone+1 (510) 204-7200
- Websitehttps://xoma.com/
More ▼
Mergers & acquisitions
| Acquired company | XOMA:NMQ since announced | Transaction value |
|---|---|---|
| Generation Bio Co | -1.43% | 57.89m |
| HilleVax Inc | 0.36% | 97.78m |
| LAVA Therapeutics NV | 0.36% | 32.61m |
| Turnstone Biologics Corp | -9.00% | 5.85m |
Data delayed at least 15 minutes, as of Feb 06 2026 21:00 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Linmon Media Ltd | 124.70m | -18.11m | 161.91m | 185.00 | -- | 0.4814 | -- | 1.30 | -0.3928 | -0.3928 | 2.69 | 7.27 | 0.2638 | 0.9167 | 3.02 | 4,800,048.00 | -3.84 | -3.78 | -4.52 | -9.46 | 19.23 | 37.58 | -14.54 | -10.63 | 3.70 | -62.60 | 0.0692 | -- | -46.22 | -18.20 | -188.54 | -- | 59.75 | -- |
| Crisp Momentum Inc | 270.00 | -8.09m | 227.51m | 0.00 | -- | -- | -- | 842,622.10 | -0.0201 | -0.0201 | 0.00 | -0.0002 | 0.0017 | -- | -- | -- | -5,218.35 | -- | -- | -- | 48.15 | -- | -2,994,656.00 | -- | -- | -9.91 | -- | -- | -99.27 | -- | -939.01 | -- | -- | -- |
| Powersoft SpA | 89.03m | 13.30m | 241.28m | 266.00 | 17.42 | 5.38 | 13.78 | 2.71 | 0.9154 | 0.9154 | 6.12 | 2.96 | 0.8278 | 1.44 | 6.53 | 444,662.30 | 12.37 | 16.05 | 17.12 | 22.51 | 51.55 | 47.01 | 14.94 | 13.80 | 1.17 | 24.72 | 0.6566 | 79.85 | 3.08 | 14.10 | 2.35 | 32.57 | 47.53 | -- |
| YH Entertainment Group | 119.75m | 10.69m | 261.47m | 221.00 | 24.73 | 1.22 | 14.93 | 2.18 | 0.0995 | 0.0995 | 1.11 | 2.01 | 0.4157 | 80.07 | 11.77 | 4,520,684.00 | 3.80 | 29.18 | 4.91 | 45.60 | 21.21 | 37.96 | 9.15 | 47.83 | 2.31 | -- | 0.0437 | 17.68 | 1.17 | 3.90 | 133.33 | -16.98 | -7.09 | -- |
| XOMA Royalty Corp | 47.11m | 9.87m | 308.59m | 13.00 | 33.40 | 3.49 | 16.90 | 6.55 | 0.7462 | 0.7462 | 2.87 | 8.77 | 0.1937 | -- | 20.40 | 3,623,539.00 | 8.90 | -5.17 | 9.90 | -5.64 | -- | -- | 45.94 | -39.94 | -- | 1.71 | 0.5018 | -- | 498.72 | 9.17 | 58.33 | -- | -- | -- |
| Digital Domain Holdings Ltd | 99.49m | -35.72m | 311.44m | 910.00 | -- | 5.53 | -- | 3.13 | -0.035 | -0.035 | 0.0974 | 0.0551 | 0.6577 | -- | 8.94 | 867,678.60 | -24.49 | -36.14 | -34.30 | -47.11 | 22.87 | 17.25 | -37.24 | -63.01 | -- | -2.78 | 0.5699 | -- | -15.03 | 2.69 | 23.90 | -- | -13.37 | -- |
| Franchise Brands PLC | 189.10m | 10.70m | 343.43m | 646.00 | 32.18 | 1.15 | 10.51 | 1.82 | 0.0407 | 0.0407 | 0.7191 | 1.14 | 0.3721 | 7.79 | 3.04 | 216,373.10 | 2.11 | 2.72 | 2.42 | 3.21 | 58.67 | 52.32 | 5.66 | 5.49 | 1.09 | 2.84 | 0.2635 | 59.25 | 15.03 | 25.90 | 143.86 | 21.87 | 12.94 | 20.36 |
| Avex Inc | 888.87m | 2.36m | 345.33m | 1.46k | 136.27 | 1.01 | 27.06 | 0.3885 | 8.67 | 8.67 | 3,286.70 | 1,163.72 | 1.29 | 17.51 | 6.50 | 95,805,080.00 | 0.4738 | 3.70 | 0.9667 | 6.91 | 27.11 | 30.88 | 0.3675 | 3.49 | 1.29 | -- | 0.00002 | 75.03 | -1.27 | -0.5641 | 15.30 | -- | 8.48 | 0.00 |
| Gaumont SA | 141.46m | -14.97m | 367.43m | 227.00 | -- | 1.74 | 6.54 | 2.60 | -4.07 | -4.07 | 38.45 | 57.56 | 0.3104 | 34.74 | 2.23 | 517,750.00 | -3.31 | -1.69 | -5.96 | -2.78 | 91.02 | 92.49 | -10.66 | -4.08 | 0.9309 | -12.21 | 0.0966 | -- | -12.85 | -6.68 | -108.36 | -- | -10.61 | -- |
| TVZone Media Co Ltd | 39.54m | -3.93m | 389.54m | 423.00 | -- | 5.88 | -- | 9.85 | -0.2099 | -0.2099 | 2.11 | 3.54 | 0.3216 | 6.14 | 1.84 | 648,566.80 | -3.68 | -0.4499 | -4.66 | -0.5462 | 20.37 | 18.85 | -11.44 | -1.35 | 2.71 | -- | 0.2849 | -- | 29.37 | 2.22 | -96.46 | -- | 49.58 | -- |
Data as of Feb 06 2026. Currency figures normalised to Xoma Royalty Corp's reporting currency: US Dollar USD
59.74%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BVF Partners LPas of 30 Sep 2025 | 2.59m | 20.92% |
| Morgan Stanley Investment Management, Inc.as of 30 Sep 2025 | 1.64m | 13.21% |
| Fidelity Management & Research Co. LLCas of 30 Sep 2025 | 1.04m | 8.38% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 630.90k | 5.10% |
| BlackRock Fund Advisorsas of 30 Sep 2025 | 544.18k | 4.40% |
| Opaleye Management, Inc.as of 30 Sep 2025 | 255.09k | 2.06% |
| Geode Capital Management LLCas of 30 Sep 2025 | 211.98k | 1.71% |
| Woodline Partners LPas of 30 Sep 2025 | 209.95k | 1.70% |
| SSgA Funds Management, Inc.as of 30 Sep 2025 | 167.04k | 1.35% |
| Stonepine Capital Management LLCas of 30 Sep 2025 | 115.46k | 0.93% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
